Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Giving Patients a Meaningful Voice in United States Regulatory Decision Making: The Role for Health Preference Research.

Literature DB >> 28597374

Giving Patients a Meaningful Voice in United States Regulatory Decision Making: The Role for Health Preference Research.

F Reed Johnson¹, Kathleen Beusterien², Semra Özdemir³, Leslie Wilson⁴.

Abstract

Entities: Species

Mesh：

Year: 2017 PMID： 28597374 DOI： 10.1007/s40271-017-0250-z

Source DB: PubMed Journal: Patient ISSN： 1178-1653 Impact factor: 3.883

× No keyword cloud information.

4 in total

1. The future of population-based postmarket drug risk assessment: a regulator's perspective.

Authors: T A Hammad; G A Neyarapally; S Iyasu; J A Staffa; G Dal Pan
Journal: Clin Pharmacol Ther Date: 2013-06-05 Impact factor: 6.875

2. Conjoint analysis applications in health--a checklist: a report of the ISPOR Good Research Practices for Conjoint Analysis Task Force.

Authors: John F P Bridges; A Brett Hauber; Deborah Marshall; Andrew Lloyd; Lisa A Prosser; Dean A Regier; F Reed Johnson; Josephine Mauskopf
Journal: Value Health Date: 2011-04-22 Impact factor: 5.725

3. Approving a Problematic Muscular Dystrophy Drug: Implications for FDA Policy.

Authors: Aaron S Kesselheim; Jerry Avorn
Journal: JAMA Date: 2016-12-13 Impact factor: 56.272

4. Incorporating patient-preference evidence into regulatory decision making.

Authors: Martin P Ho; Juan Marcos Gonzalez; Herbert P Lerner; Carolyn Y Neuland; Joyce M Whang; Michelle McMurry-Heath; A Brett Hauber; Telba Irony
Journal: Surg Endosc Date: 2015-01-01 Impact factor: 4.584

4 in total

14 in total

1. Towards Meaningful Engagement for the Patient Voice.

Authors: Peter J Pitts
Journal: Patient Date: 2019-08 Impact factor: 3.883

2. Incorporating Quantitative Patient Preference Data into Healthcare Decision Making Processes: Is HTA Falling Behind?

Authors: David John Mott
Journal: Patient Date: 2018-06 Impact factor: 3.883

3. Key Issues and Potential Solutions for Understanding Healthcare Preference Heterogeneity Free from Patient-Level Scale Confounds.

Authors: Catharina G M Groothuis-Oudshoorn; Terry N Flynn; Hong Il Yoo; Jay Magidson; Mark Oppe
Journal: Patient Date: 2018-10 Impact factor: 3.883

4. Engagement of Canadian Patients with Rare Diseases and Their Families in the Lifecycle of Therapy: A Qualitative Study.

Authors: Andrea Young; Devidas Menon; Jackie Street; Walla Al-Hertani; Tania Stafinski
Journal: Patient Date: 2018-06 Impact factor: 3.883

5. Advancing the Use of Patient Preference Information as Scientific Evidence in Medical Product Evaluation: A Summary Report of the Patient Preference Workshop.

Authors: Heather L Benz; Ting-Hsuan Joyce Lee; Jui-Hua Tsai; John F P Bridges; Sara Eggers; Megan Moncur; Fadia T Shaya; Ira Shoulson; Erica S Spatz; Leslie Wilson; Anindita Saha
Journal: Patient Date: 2019-12 Impact factor: 3.883

6. Do preferences differ based on respondent experience of a health issue and its treatment? A case study using a public health intervention.

Authors: David J Mott; Laura Ternent; Luke Vale
Journal: Eur J Health Econ Date: 2022-06-18

10. Patient Perspectives on the Value of Patient Preference Information in Regulatory Decision Making: A Qualitative Study in Swedish Patients with Rheumatoid Arthritis.

Authors: Karin Schölin Bywall; Jorien Veldwijk; Mats G Hansson; Ulrik Kihlbom
Journal: Patient Date: 2019-06 Impact factor: 3.883